VR Logo

Aspira Pathlab & Diagnostics: Announcement Under Regulation 30 (LODR)-Continuation Of Directorship Of Dr. Subhash Salunke As Independent Director Of The Company


Dear Sir/Madam Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held on Saturday August 13 2022 has approved the Continuation of Directorship of Dr. Subhash Salunke as Independent Director of the Company.The Information required to be submitted pursuant to Regulation 30 of the Listing Regulations is marked and attached as Annexure.

Click here to view PDF